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Immunoblot and an enzyme-linked immunosorbent assays were used to evaluate and compare IgG antibodies against 
S. aureus whole cell lysate, cell wall peptidoglycan and lipoteichoic acid to discriminate between deep-seated and 
superficial S. aureus infection. Serum samples were examined from patients with deep-seated (n = 25) and superficial (n 
= 25) S. aureus infections and 15 healthy controls. Patients with deep-seated infections exhibited a large number of 
immuno-reactive bands in their IgG immunoblot profile as compared to those with superficial infections and healthy 
controls. Anti-staphylococcal IgG antibodies that reacted with two antigens of apparent molecular weight 110 and 98 
kDa were specifically present in 96% (24/25) of patients with deep-seated infections, and were absent in, superficial and 
control sera. Moreover other Gram-positive and Gram-negative bacteria did not share these two unique antigens. The 
ELISA assays revealed significantly elevated levels of IgG antibodies to peptidoglycan (PG) in 18 of 25 (72%) patients 
with deep infection and 15 of 25 (60%) patients with superficial staphylococcal infection. The elevated levels of IgG 
antibodies to teichoic acid (TA) antigen were detected in all (100%) deep-seated group patients and among 40% (10/25) 
patients with superficial infection. An increase in levels of antibodies to PG showed a positive correlation trend with 
levels of IgG antibodies to TA only in deep infection group. Thus immunoblot detection of these two unique antigens as 
well as detection of elevated antibodies against PG and TA may be useful for the discrimination of staphylococcal deep-
seated and superficial infection in humans. 
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1.  Introduction 
Staphylococcus aureus, being a highly versatile 
organism, has the capacity to establish infections in a wide 
range of body sites.  The infections caused by this species 
are often acute and pyogenic and, if untreated may spread 
to surrounding deeper tissues or to metastatic sites 
involving other organs, resulting in disseminated or deep-
seated infections which are life threatening [1]. It is one of 
the most successful human pathogens with ability to 
colonize and infect both hospitalized patients with or 
without compromised host defenses and healthy 
immunologically competent people in the community[2]. 
Further, the recent reports of reduced susceptibility to 
vancomycin [3] highlight the importance of 
understanding molecular epidemiology of S. aureus 
infections. 
S. aureus has a diverse arsenal of components and 
products that contribute to the pathogenesis of infections. 
A great deal is known about the contribution of these 
bacterial factors to the development of infection, [1] 
considerably less is known about the host factors. 
Moreover approximately 30% of healthy individuals are 
colonized by S. aureus, usually in their anterior nares 
which serves as the major reservoir form where the 
organism can spread to the other parts of the body [4]. The 
proposed pathogenesis for endogenous infection would 
be that from the nose, the skin become colonized causing 
subsequent infection in patients with impaired skin site [5, 
6].  Recent studies have shown that mucin appears to be a 
critical host surface, which is colonized, involves the 
interactions between staphylococcal proteins and mucin 
carbohydrate [4, 7]. The role of other factors such as 
secretory IgA is not clear. Immunity to S. aureus infections 
and its role in pathogenesis remain poorly understood [8]. 
Although, there appears to be a little resistance to mucosal 
colonization by S. aureus, healthy individuals have a high 
degree of innate resistance to invasive staphylococcal 
infections [9].  Natural immunity in the host is attributed 
to epidermal and mucosal surface barriers and to intact 
cellular and humoral immune defense. Due to repeated 
natural exposure to S. aureus (as a constituent of normal 
flora) antibodies to S. aureus exoproteins and cell wall 
components peptidoglycan (PG) [10], teichoic acid (TA) 
[11] and capsule are prevalent in humans [9]. But titers of 
these anti-staphylococcal antibodies are elevated after 
severe infections and this view is supported by a number 
of studies, which have shown that significantly elevated 
levels of antibodies to TA or PG can be detected in the 
vast majority of patients with S. aureus invasive infections 
[12, 13].  Many of these studies have demonstrated the rise 
in titer of antibodies against TA and PG during infections, 
but they in general, failed to reveal a correlation between 
antibody titer and immunity to these infections [10]. One 
exception is that antibodies to the staphylococcal 
exoprotein TSST-1 are associated with immunity to 
staphylococcal toxic shock syndrome in humans [14]. The 
data regarding the presence of antibodies during 
superficial  S. aureus infections are not evaluated 
systematically. 
In this study we therefore aimed at analyzing 
antibody responses against S. aureus whole cell lysate and 
its cell wall antigens in patients with deep-seated and Int. J. Med. Sci. 2005 2  130
superficial staphylococcal infection. The comparison of 
antibody levels and responses might thus identify the 
patients with more risk of life threatening deep-seated 
infection as compare to self-limiting superficial infections. 
Furthermore the presence of an antibody response against 
these antigens may also add diagnostic information when 
patients with putative invasive S.  aureus infection are 
being evaluated. 
2.  Material and Methods 
2.1. Study population 
This study was approved by Institutional Ethics 
Committee and Dean’s Doctoral Committee. A total of 50 
patients were enrolled in the study. Group I include 25 
consecutive cases admitted in Nehru Hospital, PGIMER, 
Chandigarh, India with clinical evidence of sepsis and 
bacteriological evidence of deep-seated S. aureus infections 
as evidenced by isolation of organism from blood or an 
aspirate from deep-seated normally sterile site. Cases of 
prior trauma or penetrating injury were excluded. Group 
II consisted of another 25 consecutive cases with evidence 
of bacteriological proven S. aureus infection limited to skin 
and/or subcutaneous soft tissue without any clinical or 
bacteriological evidence of invasion into deeper tissues. 
Fifteen healthy persons without any history of sepsis in 
the preceding three months were taken as controls. Single 
serum samples were obtained from all the subjects 
including the patients and healthy controls and preserved 
at –20°C till further use. 
2.2. Bacterial strains  
A total of 50 clinical isolate of S. aureus from the two 
groups of patients were obtained from clinical 
bacteriology laboratory, department of Medical 
Microbiology, PGIMER, Chandigarh, India. A standard 
strain of S. aureus (ATCC-12600) was obtained from 
Microbial Type Culture Collection (MTCC) center of 
Institute of Microbial Technology, Sector 39, Chandigarh. 
This strain was used as reference strain. 
The clinical isolates were identified on the basis of 
colony characteristics, gram stain morphology, coagulase 
production and mannitol fermentation [15]. All the strains 
were preserved in semisolid agar butts at 4°C and in BHI 
broth (Hi Media) with 15% glycerol at –70°C till further 
use.  
2.3. Preparation of whole cell lysate 
All clinical isolates and the reference strain were 
plated on BHI agar plates and incubated at 37°C for 24h. 
A sweep of 4-6 colonies from these plates were inoculated 
into flasks containing 10ml of BHI broth and incubated at 
37°C overnight in an orbital shaker. Subsequently, 1 mL of 
this growth culture was added to 50 mL of fresh medium 
and incubated at 37°C with constant shaking (150 rpm) for 
8 to 10 hours, and bacterial growth was monitored by 
taking aliquots and measuring OD600 at various time 
intervals. The culture was stopped at mid-logarithmic 
phase (OD600 ≤ 0.5). The resulting broth cultures were 
centrifuged at 10,000g for 15 m at 4°C. The supernatant 
was discarded and the pellets were washed twice in sterile 
PBS (pH 7.2). The pellets were finally resuspended in 
equal volume of sterile PBS and disrupted by shaking 
with glass beads (Braun; cell disruptor) for 2-3 min under 
constant cooling by liquid CO2 till 90% of the cells were 
broken. The unbroken cells were deposited by 
centrifugation at 12,000g for 30 m at 4°C and the 
supernatant was preserved at –70°C till further use. The 
protein content of the samples was estimated by method 
of Bradford [16] and adjusted to give a final conc. of 2-
3mg/ml. 
2.4. Sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) 
Whole-cell protein profile of all S. aureus isolates was 
analysed by SDS-PAGE following the discontinuous 
buffer system of Laemmli [17]. Samples were prepared for 
PAGE by mixing in proportions of one part sample to 3 
parts of sample buffer and boiling for 5 min. Solubilised 
samples (20µl) were applied to wells in a 4% acrylamide 
stacking gel over a 10% acrylamide separating gel. 
Electrophoresis was performed using a Bio-Rad Mini-
Protean-II® apparatus with vertical slab gel 7cm (L) x 8cm 
(W) x 0.75 mm (T). The gels were run at constant voltage 
of 175V until the bromophenol blue dye had reached the 
bottom over a period of 45 min-1hr. Broad range 
molecular weight markers (Bio-Rad) were also run for 
molecular weight estimation of bands of interest. After the 
completion of electrophoresis the gels were removed and 
stained with Coomassie Brilliant Blue R-250. The gels 
were photographed and protein profiles of the isolates 
were compared. 
2.5 Immunoblotting 
The whole cell lysate of the clinical isolates and 
reference strain were run in SDS-PAGE as mentioned 
earlier using a Bio-Rad Mini-PROTEAN II® apparatus 
following manufacturer’s instructions. Gels were 
equilibriated in transfer buffer and the separated proteins 
were transferred onto nitrocellulose (NC) paper (pore 
diameter, 45µm) as described by electrophoretic transfer 
method of Towbin et al. [18], using a Bio-Rad Mini 
TransBlot® cell at 100mA for 90 m at 4°C in transfer 
buffer. 
After transfer the NC paper was cut vertically into 
strips, which were washed twice in PBS and soaked in 
blocking buffer overnight at 4ºC. For characterization of 
serological response of patients to blotted and blocked 
NCP strips, patient sera diluted 1:100 in PBST containing 
1% BSA were added to individual strips. After incubation 
at 37ºC for 1 hr at 37ºC, the strips were washed on a 
rotatory shaker with five changes of PBST for 10 m each. 
Anti-human IgG-HRPO conjugate (Dako) diluted 1:1000 
in PBST-BSA were added to each strip and incubated for 
another one hour at 37ºC. Following five washings for 10 
m each the strips were developed by soaking for 5 m in 
developing solution containing 0.05%(w/v) diamino-
benzidine tetrahydrochloride and 1% H2O2 i n  P B S .  T h e  
blots were dried and photographed. 
2.6 Preparation of S. aureus cell wall antigens 
S. aureus  grown on nutrient agar plates overnight 
were resuspended in distilled water and heated at 70ºC 
for 1 hr. The bacteria were centrifuged, rinsed twice with 
distilled water, twice with acetone and dried. Cells were 
disrupted in cell homogenizer (Braun, Germany) with 
glass beads (0.17-0.18 mm dia). Residues upon 
centrifugation at 3,000 rpm for 10 min were discarded and 
from the supernatant cell wall were sedimented by 
centrifugation at 13,000 rpm for 25 min and rinsed 3 times 
with distilled water. Cell wall pellet was resuspended in 
phosphate buffer (pH 7.6) containing trypsin (200 µg/ml), 
RNase (100µg/ml) and DNase (50µg/ml) and incubated at Int. J. Med. Sci. 2005 2  131
37ºC for 18 h, rinsed 3 times with distilled water and 
lyophilized. 
2.6.1 Teichoic Acid extraction 
Teichoic acid was extracted from cell wall fractions 
with 5% TCA at room temp 3 times overnight on shaker 
(1g cell wall per 250 ml, 160 ml, and 100 ml of TCA). Three 
aliquots of supernatant were pooled and extracted 3 times 
with double volume of ethyl ether each time and then 
precipitated with 3 volumes of acetone at 4°C for 24 hrs. 
Delicate precipitates of teichoic acid were centrifuged and 
washed with acetone and dried. 
2.6.2 Peptidoglycan preparation 
The residue remaining from cell wall extraction with 
TCA was heated at 90ºC for 15 min, washed with water 3 
times, followed by acetone and dried. This fraction was 
used as peptidoglycan in all experiments as described by 
Kotani et al [19, 20]. 
In addition commercially available Staphylococcus 
aureus peptidoglycan and teichoic acid purchased from 
Sigma were also included in ELISA experiments. 
2.7 ELISA  
The modification of the technique originally 
described by Engvall and Perlamann [21] was used to 
quantitate IgG antibodies against cell walls  peptidoglycan 
(PG) and teichoic acid (TA) in patients and healthy control 
sera. One hundred microliters of antigen solution 
(10µg/ml) in carbonate buffer (pH 9.6) was added to flat 
bottom microtiter plate  (Maxisorp, Nunc, Denmark) wells 
and left to adsorb for 1 h at 37ºC and then overnight at 
4ºC. The plates were then washed (SLT washer, Austria) 
in PBST. The unbound sites on the plastic surface were 
blocked with 200µl of PBS containing 2% BSA. The 
blocking agent was left for 6 h at room temperature and 
then overnight at 4ºC. The plates were washed 3 times 
with PBST and 100µl of patient serum diluted 1:1000 in 
PBST containing 1% BSA was added to each well and the 
plate was kept for incubation at 37ºC for 1h. After 
washing (five times) 100µl of anti-human IgG-HRP 
conjugate diluted in PBST containing 1% BSA was added 
and incubated at 37°C for 1 h. After washing 100µl of 
substrate containing 10mg of orthophenylene diamine 
(OPD) in 25ml of citrate-phosphate buffer was added to 
each well. After 15-20 mins at room temperature, the 
reaction was stopped with 50µl of 2.5 M H2SO4. The plates 
were read in an automated ELISA reader (340 ATC, SLT, 
Austria) at 492 nm using a reference wavelength of 620 
nm. The results of the assay were expressed as the mean 
optical density at 492 nm of the duplicate values. 
Statistical analysis was performed using ANOVA and p < 
0.05 were considered to be significant. 
3.  Results 
3.1 Demographics 
A total of 50 patients and 15 healthy controls were 
enrolled in the study. The patients with deep-seated 
infections had deep abscesses (n = 8), sepsis (n = 5), 
endocarditis (n = 4), pyomyositis (n = 3), septic arthritis 
and osteomyelitis (n = 2 each) and empyema (n = 1). The 
mean age of patients in this group was 24.5 years (range, 4 
to 65 years). Patients with superficial infections had 
pyoderma (n = 11), folliculitis (n = 8), subcutaneous 
abscesses (n= 5) and sty (n = 1) and the mean age in this 
group was 21.1 years (range, 4 to 52 years). The patients 
with deep-seated infections were admitted in different 
wards of Nehru Hospital, PGIMER, Chandigarh during a 
period of 2 years from Jan 1999 to March 2001, while the 
majority (80%) of patients with superficial infections 
enrolled in the study were taken from skin OPD over a 
period of 3 months March 2001 to May 2001. The S. aureus 
strains from clinical specimens of hospitalized patients 
were recovered within two to three days after 
hospitalization, whereas strai n s  w e r e  i s o l a t e d  n e x t  d a y  
from those appearing in OPDs (particularly skin). Serum 
samples were also collected same day before the start of 
antibiotic therapy. 
3.2 S. aureus strains causing deep-seated and superficial 
infection had identical protein profile 
Recently, S. aureus strains have been shown to have 
an association to the type of infection [22]. In order to 
compare the whole cell protein profile of S. aureus strains 
associated with deep-seated and superficial infection, 
whole cell lysates of isolates of both the groups were 
subjected to SDS-PAGE. Both deep and superficial isolates 
showed almost identical protein profile which consisted of 
25-30 bands with major bands having molecular weights 
of approximately 120, 92, 80, 66, 55, 42, 36, 29, 24, 20, 18 
and 16 kDa (Fig 1).  
The protein profiles of isolates within the same 
group were grossly similar. More than 90% of the bands 
were qualitatively and quantitatively identical with minor 
quantitative difference in the intensity of the others. No 
significant inter strain variation was found among the 
deep and superficial isolates regarding their whole cell 
protein profile. 
3.3 Immunoblot profile can discriminate between deep-
seated and superficial infection 
The IgG antibody response to whole cell lysate of 
Staphylococcus aureus during infection was examined 
qualitatively by immunoblot analysis of sera from patients 
of both the group. Figure 2 shows the IgG immunoblot 
profile of the sera of patients with deep-seated and 
superficial infections respectively. Sera from patients with 
deep-seated staphylococcal infections exhibited a large 
number of bands in their IgG western blot profile (Fig; 2A) 
as compared to those with superficial infections (Fig; 2B). 
The banding patterns within each group of patients were 
grossly similar with minor individual variations. The most 
prominent band present in both superficial and deep 
patient sera had molecular weight of approximately 60 
kDa. This band was also detected in healthy controls (data 
not shown). In addition to this common band, the 
immunoblot profile of deep-seated group of patients 
showed the presence of two unique bands with molecular 
weights of 110 kDa and 98 kDa which were detected in 
96% of patients of this group but were totally absent in 
patients with superficial infection and healthy individuals.  
3.4 The 110 and 98 kDa immunodominant peptide of S. 
aureus are not shared by other bacteria 
In order to demonstrate the species specificity of 
these two unique bands present in IgG immunoblot 
profile of patient sera from deep-seated infections, pooled 
sera from patients of both the groups and healthy controls 
were checked against whole cell proteins of other Gram-
positive [S. epidermidis and clinical isolates of coagulase-
negative staphylococci (CONS)] and Gram-negative (E. 
coli, Klebsiella spp) bacteria. The results of this experiment 
showed that these two bands were present only in cases Int. J. Med. Sci. 2005 2  132
with deep seated infections (Fig. 3A) and absent from 
those with superficial infections (Fig. 3B) and healthy 
controls (Fig. 3C). Moreover these antigens were not 
shared by other Gram-positive and Gram-negative 
bacteria tested. 
3.5. Anti-staphylococcal antibodies react with PG and TA 
We observed that levels of anti-staphylococcal IgG 
antibodies were very similar when total bacterial lysate or 
whole S. aureus cells were used as coating antigens (data 
not shown). These results suggested that the majority of 
antistaphylococcal IgGs reacted  with the surface of the 
pathogen. TA and PG, the two most abundant cell wall 
components, have been known to be highly immunogenic 
in humans. Consistent with this notion, the quantitative 
measurement of IgG antibodies to peptidoglycan and 
teichoic acid in sera from patients and healthy controls 
was checked by ELISA.  
The  sera obtained from both patients and healthy 
controls showed great variability  in levels of antibodies 
against  S. aureus cell wall antigens (table 1). Sera from 
patients were considered positive if the OD exceeded the 
mean OD of healthy control sera plus one SD. Elevated 
levels of IgG antibodies to teichoic acid antigen were 
detected in 100% (25/25) patients with deep-seated 
infections and 40% (10/25) of patients with superficial 
infection. About 72% (18/25) of patients among deep 
group and 60% (14/25) among superficial had 
significantly elevated antibodies against peptidoglycan 
(Fig. 4).  The levels of antibodies against cell wall antigens 
also varied within each group, amongst deep infection 
group 4 of 25 patients who had staphylococcal 
endocarditis and two patients with osteomyelitis were 
found to have higher antibodies to TA and PG, as 
compare to other patients in this group. Similarly patients 
with folliculitis had higher levels of antibodies to PG 
among superficial group. Similar results were obtained 
when we used the commercially available PG and TA 
3.6 Correlation coefficients 
We analyzed the correlation of levels of anti- 
peptidoglycan and teichoic acid antibodies in sera from 
patients with deep-seated and superficial staphylococcal 
infections. Sera from patients with deep-seated infections 
showed weak positive correlation trend between 
antibodies to PG and TA (p < 0.1), where as on the other 
hand no significant correlation was detected among 
patients with superficial infections regarding anti PG and 
TA antibody levels (Fig. 5). 
4.  Discussion  
Staphylococcus aureus is a major human pathogen 
causing significant morbidity and mortality in both 
community and hospital acquired infections [1]. It causes 
a diverse array of infections ranging from relatively minor 
skin and wound infections to more serious and life 
threatening disease such as pneumonia, endocarditis, 
osteomyelitis, arthritis and sepsis [2]. Here in this study 
we investigated the prevalence of antibodies to the well-
characterized staphylococcal cell wall antigens PG and TA 
and total cell lysate in sera from patients with deep-seated 
and superficial S. aureus infections. We demonstared that 
the patients with deep-seated infection can be 
discriminated from those with superficial infection, which 
might thus identify the patients with more risk of life 
threatening deep-seated infection as compare to self-
limiting superficial infections.  
Immunoblotting of bacterial whole cell polypeptides, 
by the western blot technique has been used to examine 
the immune response of individuals to the large number 
of polypeptides found in whole cell extract pathogenic 
bacteria [23] including Staphylococcus aureus [24]. In a 
study of six patients with S. aureus endocarditis, 
antibodies to S. aureus and E.coli heat shock proteins were 
detected by western immunoblots, but a similar response 
was observed in sera from patients with other forms of 
endocarditis. While heat shock proteins may not be as 
specific as staphylococcal antigens studied by Colgue-
Navarro and collegues as these results emphasise that 
serological response to staphylococcal infection is complex 
partly because individuals are exposed to S. aureus from 
birth [25].   Our study has clearly demonstrated that all 
the individuals (patients and controls) investigated 
produce circulating antibodies directed against a large 
number of S. aureus polypeptides. This finding is in 
agreement with those of other workers who have 
documented those most human sera posses a variety of 
anti-staphylococcal antibodies [26].  Despite the 
complexity of immune response many polypeptides in the 
cell extract gave negative reaction in the western blot 
a n a l y s i s .  I t  i s  l i k e l y  t h a t  t h e  i m m u n e  r e s p o n s e  a g a i n s t  
some polypeptides may be poor because they are 
intrinsically poor antigens, because of their structure or 
other factors [27]. Western blot of IgG response of patients 
with deep-seated infections showed antibodies against a 
large number of polypeptides as compared to those with 
superficial infections. In immunoblot profile of deep-
seated patients we identified two unique polypeptides of 
molecular weights of approximately 110 kDa and 98 kDa, 
which were detected exclusively in 96% of patients with 
deep-seated infection, and they were absent in superficial 
group and healthy control group. These two unique bands 
are likely to be of diagnostic value. The diagnostic efficacy 
of antibody detection tests was not the primary objective 
of this study and these findings need to be further 
evaluated in larger group of patients and healthy 
individuals. In addition further characterization of these 
two polypeptide antigens is required to evaluate their 
potential role in diagnosis of these two groups of patients.  
In recent years attention has been focused on the 
measurement of antibody to cell wall antigens in patients 
with proven S. aureus infection [28]. Teichoic acid and 
peptidoglycan are the major components of 
staphylococcal cell wall and they are known to induce 
inflammatory response in humans [29]. Antibodies 
against PG and TA antigens have been successfully titred 
in serological assays [28, 30, 31].  Humoral immune 
response to S. aureus infections is complex and despite the 
fact that α-toxin, teichoic acid and lipase are widely 
recognized as staphylococcal virulence determinants, the 
production of antibodies to one or more antigens is 
variable. Colque-Navarro and colleagues acknowledge 
that the kinetics of the antibody response differs greatly 
between patients [25]. In our study, we also observed 
variable antibody response against S. aureus cell wall 
antigens peptidoglycan and teichoic acid between both 
the groups of patients and healthy controls. Studies are 
available which have shown the increased IgG titer 
against teichoic acid [32] in patients with deep-seated 
staphylococcal infections (especially in cases of 
endocarditis and ostemyelitis). We also observed that all 
(25/25) of the patients with deep-seated infection had 
elevated levels of IgG antibodies against TA, even with in Int. J. Med. Sci. 2005 2  133
the group of patients with endocarditis and osteomyelitis 
showed higher levels than rest of the group. Two healthy 
controls also exhibited higher antibodies against this 
antigen. Previous staphylococcal infections or non-specific 
antibody responses may be a significant factor in partly 
explaining the high initial antibody levels [33, 34]. In 
contrast, failure to mount an antibody response against 
PG in some of the patients with deep infection might be 
due to impaired immunity of advancing age, poor 
expression of virulence determinants by the infecting 
strain or changes in the immune response resulting from 
infection itself. 
Verbrugh et al. [35], in 1986 undertook one study to 
compare the antibody response to α-toxin, teichoic acid 
and peptidoglycan in patients with complicated and 
uncomplicated infections.  Neither single test was able to 
detect complicated bacteraemia in all patients nor there do 
any test that was totally specific in this respect. 
Sensitivities ranged from 64% for assay of Abs against 
teichoic acid to 72% for assays of antibody to 
peptidoglycan and α-toxin. The specificity of assays for 
antibody to cell wall antigens (peptidoglycan and teichoic 
acid) was 79% whereas this specificity was 50% for α-
toxin. Our data indicated a positive correlation trend 
between raised levels of antibodies to PG and TA among 
deep infection group, but surprisingly no correlation was 
detected among superficial infection group. 
In conclusion our data indicated that patients with 
deep-seated and superficial staphylococcal infection can 
be discriminated on the basis of their immunoblot profile 
against total S. aureus cell lysate as well as their serum IgG 
response to cell wall antigens peptidoglycan and teichoic 
acid. Whether the presence of antibodies against these cell 
wall antigens of S. aureus decreases or enhances the 
outcome of staphylococcal infection is still not clear. 
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Tables and Figures 
Table 1. IgG antibody levels against PG and TA in sera from 
healthy individuals and patients with deep-seated and superficial 
staphylococcal infections.  
 
Healthy 









Infection (n = 25) 
S. aureus cell 
wall 
Antigens 
Mean*  SD*  CV Mean* SD* CV  Mean* SD* CV 
Peptidoglycan 0.78 0.29 
 
0.37  1.05a 0.57  0.54 1.39 a 0.70  0.50 
Teichoic acid  0.49  0.20 
 
0.41  0.52 0.34  0.65 1.29 a 0.63  0.48 
SD, Standard deviation; CV, coefficient of variation 
* Mean and SD are given as ODs at 492 nm. 
a  p < .05 
Figure 1.  Whole-cell protein profile of representative S. 
aureus strains. Clinical isolates of S. aureus were taken from 
patients with deep-seated (A) and superficial staphylococcal 
infection (B). The crude protein extracts were separated by 
SDS–PAGE and stained with Coomassie blue. Lane M; 
molecular weight marker; Lane A; standard S. aureus strain 
(ATCC 12600); Lane 1-6; whole cell lysates of representative S. 
aureus isolates. Figures are representative of two independent 
experiments. 
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Figure 2.  Immunoblot profiles of patients with deep-seated 
and superficial S. aureus infection. Whole cell protein lysate 
of S. aureus (ATCC 12600) was separated by SDS–PAGE and 
transferred onto nitrocellulose membranes which were probed 
with serum (1:1000) from patients with deep-seated (A) and 
superficial (B) infection. Each lane represents serum from 
individual patients. Serum samples were drawn 2-3 day after 
detection of S. aureus in clinical specimens. Results are 
representative of two independent experiments. 
 
 
Figure 3.  Western blot analysis of S. aureus 
immunodominant antigens. Whole cell protein lysate of S. 
epidermidis (lane 1), S. aureus (lane 2), clinical isolates of 
coagulase negative staphylococci (lane 3-5), E. coli (lane 5) and 
Klebsiella sp (lane 6) were separated by SDS–PAGE and 
transferred onto nitrocellulose membranes and probed with 
pooled serum (1:1000) from patients with deep-seated (A) and 
superficial (B) infection and healthy controls (C). Results are 
representative of three independent experiments.  
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Figure 4.  Levels of antistaphylococcal IgG antibodies.  
Antibodies against S. aureus cell wall antigen peptidoglycan (A) 
and teichoic acid (B) were measured ELISA in sera (1:1000) 
from helathy individuals and patients with superficial and deep-
seated infection. Violin plots were constructed on the basis of 
OD 492 nm to show the distribution IgG antibody levels in each 
group. Data are the representative of three independent 
experiments.  
 
Figure 5.  Correlation plots of antibodies to PG and TA.   
Antibody levels against peptidoglycan and teichoic acid in 
patients with superficial (A) and those with deep-seated (B) as 
measured by ELISA were plotted against each other to elucidate 
correlation. Coefficient of correlation was determined by r
2 
values as shown. Results represent the values of experiment in 
duplicates. 
 